Hypertensive disorders of pregnancy: the United States perspective
- 1 April 2008
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Obstetrics and Gynecology
- Vol. 20 (2), 102-106
- https://doi.org/10.1097/gco.0b013e3282f73380
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Angiogenic factors for the prediction of preeclampsia in high-risk womenAmerican Journal of Obstetrics and Gynecology, 2007
- Second-trimester angiogenic factors as biomarkers for future-onset preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2007
- Soluble endoglin as a second-trimester marker for preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2007
- Biomarker for hypertension-preeclampsia: are we close yet?American Journal of Obstetrics and Gynecology, 2007
- Sequential Changes in Antiangiogenic Factors in Early Pregnancy and Risk of Developing PreeclampsiaHypertension, 2007
- Circulating Angiogenic Factors in Early Pregnancy and the Risk of Preeclampsia, Intrauterine Growth Restriction, Spontaneous Preterm Birth, and StillbirthObstetrics & Gynecology, 2007
- Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2007
- Mapping the Theories of Preeclampsia and the Role of Angiogenic FactorsObstetrics & Gynecology, 2007
- Soluble Endoglin and Other Circulating Antiangiogenic Factors in PreeclampsiaThe New England Journal of Medicine, 2006
- Pre-eclampsiaThe Lancet, 2005